Floatz logo

Irradiated Allogeneic Cells

Loss of Chromosome 17p

Rutgers, The State University of New JerseyCell therapyEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Loss of Chromosome 17p cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Fondazione EMN Italy Onlus
Phase 2BB
Fludarabine
Institute of Hematology & Blood Diseases Hospital, China
Phase 2BB
Cyclophosphamide
City of Hope Medical Center
Phase 2B
Evomela
Institute of Hematology & Blood Diseases Hospital, China
Phase 2B
TACROLIMUS
City of Hope Medical Center
Phase 2B

View all 18 →

Same molecule, other indications

Irradiated Allogeneic Cells is also rated in:

acute myeloid leukemiaDormant
C
Indicative ·
39 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
C
Indicative ·
39 / 100
View asset →
myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2Dormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →